report by BlackRock
Results for ""
Market Outlooks
Global Weekly Commentary: Our latest credit views
This piece is approved to use with clients.
We have closed our tactical underweight in EM debt as easy monetary policy is expected to stay, against the background of an improved 2021 outlook. Positive news on Covid vaccine development has boosted the case for an accelerated global restart in 2021.
Market Outlooks
Global Markets Weekly Update: November 27, 2020
This piece is approved to use with clients.
Review the performance of global stock and bond markets over the past week, along with relevant insights from T. Rowe Price economists and investment professionals.
Market Outlooks
Global Weekly Commentary: Upgrading U.S. equities
This piece is approved to use with clients.
We upgrade U.S. equities to overweight, with a preference for quality large caps riding structural growth trends – as well as smaller companies geared to a potential cyclical upswing. We prefer to look through any near-term market volatility as Covid cases surge. Positive vaccine news reinforces our outlook for an accelerated restart during 2021, reducing risks of permanent economic scarring.
Market Outlooks
Weekly Macro Update: Europe Pivots from Brexit to Biden
This piece is approved to use with clients.
The President-elect says "America's back," but Europeans (and global investors) ask "how long?"
Market Outlooks
Global Markets Weekly Update: November 20, 2020
This piece is approved to use with clients.
Review the performance of global stock and bond markets over the past week, along with relevant insights from T. Rowe Price economists and investment professionals.
Market Outlooks
Weekly Macro Update: Investor’s Guide to the Second-Most Important Economic Challenge
This piece is approved to use with clients.
After the pandemic recovery, the U.S.-China relationship will move into ever-more complicated and uncharted territory.
Market Outlooks
Global Markets Weekly Update: November 13, 2020
This piece is approved to use with clients.
Review the performance of global stock and bond markets over the past week, along with relevant insights from T. Rowe Price economists and investment professionals.
Market Outlooks
Global Weekly Commentary: Vaccines shape 2021 outlook
This piece is approved to use with clients.
Positive news on Covid vaccines gives us greater confidence that the economic restart can re-accelerate in 2021 – and that the cumulative activity loss from the virus shock will ultimately be a fraction of that seen after the global financial crisis (GFC). We prefer to look through any market volatility generated by the virus resurgence and renewed restrictions over the challenging months ahead.